Health Catalyst
HCAT
138 hedge funds and large institutions have $1.46B invested in Health Catalyst in 2020 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 53 increasing their positions, 32 reducing their positions, and 26 closing their positions.
142% more call options, than puts
Call options by funds: $5.17M | Put options by funds: $2.14M
66% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 32
48% more capital invested
Capital invested by funds: $991M → $1.46B (+$473M)
42% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 26
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
11.38% more ownership
Funds ownership: 89.39% → 100.77% (+11%)
8% more funds holding
Funds holding: 128 → 138 (+10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$65.4M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$47.1M |
| 3 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$33.5M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$28.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NVPX
Norwest Venture Partners XI
Palo Alto,
California
|
-$50.1M |
| 2 |
NVPX
Norwest Venture Partners XII
Palo Alto,
California
|
-$50.1M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$16.4M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$6.27M |
HCAT Hedge Fund Activity: Q3 2020 in Review
138 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q3 2020, worth a combined $1.46B — up 48% from $991M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new HCAT positions and 26 closed out — a net gain of 11 holders — while 53 added to existing stakes and 32 trimmed.
The largest buyer was Wells Fargo, adding an estimated $65.4M. The largest seller was Norwest Venture Partners XI, cutting an estimated $50.1M.
- 138 institutional investors held Health Catalyst (HCAT) as of Q3 2020, up from 128 in Q2 2020.
- Funds reported $1.46B of Health Catalyst stock for Q3 2020, up 48% quarter-over-quarter.
- 37 funds opened new Health Catalyst positions in Q3 2020 and 26 closed out, a net change of +11 holders.
- The largest Health Catalyst buyer in Q3 2020 was Wells Fargo, an estimated $65.4M added.
- The largest Health Catalyst seller in Q3 2020 was Norwest Venture Partners XI, an estimated $50.1M sold.
Based on aggregated 13F filings for Q3 2020.